Notice for tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
tezacaftor, ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of patients with cystic fibrosis
Therapeutic area
Respiratory